References
- Souberbielle JC, Body JJ, Lappe JM, Plebani M, Shoenfeld Y, et al.: Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmun Rev 9, 709–715, 2010. doi:10.1016/j.autrev.2010.06.009.
- Pludowski P, Holick MF, Pilz S, Wagner CL, Hollis BW, et al.: Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun Rev 12, 976–989, 2013. doi:10.1016/j.autrev.2013.02.004.
- Gaksch M, Jorde R, Grimnes G, Joakimsen R, Schirmer H, et al.: Vitamin D and mortality: individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a European consortium. PLoS One 12, e0170791, 2017. doi:10.1371/journal.pone.0170791.
- Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, and Dawson-Hughes B: Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84, 18–28, 2006. doi:10.1093/ajcn/84.1.18.
- Mondul AM, Weinstein SJ, Layne TM, and Albanes D: Vitamin D and cancer risk and mortality: state of the science, gaps, and challenges. Epidemiol Rev 39, 28–48, 2017. doi:10.1093/epirev/mxx005.
- Moukayed M and Grant WB: The roles of UVB and vitamin D in reducing risk of cancer incidence and mortality: a review of the epidemiology, clinical trials, and mechanisms. Rev Endocr Metab Disord 18, 167–182, 2017. doi:10.1007/s11154-017-9415-2.
- Hypponen E and Power C: Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr 85, 860–868, 2007. doi:10.1093/ajcn/85.3.860.
- Agency PHE-FS: National diet and nutrition survey results from years 5 and 6 (combined) of the rolling programme (2012/2013 – 2013/2014) – A survey carried out on behalf of Public Health England and the Food Standards Agency 2016.
- Alam U, Najam O, Al-Himdani S, Benoliel S, Jinadev P, et al.: Marked vitamin D deficiency in patients with diabetes in the UK: ethnic and seasonal differences and an association with dyslipidaemia. Diabet Med 29, 1343–1345, 2012. doi:10.1111/j.1464-5491.2012.03692.x.
- Hajjaj-Hassouni N, Mawani N, Allali F, Rkain H, Hassouni K, et al.: Evaluation of vitamin D status in rheumatoid arthritis and its association with disease activity across 15 countries: “The COMORA Study”. Int J Rheumatol 2017, 5491676, 2017. doi:10.1155/2017/5491676.
- Jolliffe DA, Kilpin K, MacLaughlin BD, Greiller CL, Hooper RL, et al.: Prevalence, determinants and clinical correlates of vitamin D deficiency in adults with inhaled corticosteroid-treated asthma in London, UK. J Steroid Biochem Mol Biol 175, 88–96, 2018.
- Hirani V, Tull K, Ali A, and Mindell J: Urgent action needed to improve vitamin D status among older people in England! Age Ageing 39, 62–68, 2010. doi:10.1093/ageing/afp195.
- Davies L and Weickert MO: Gastroenteropancreatic neuroendocrine tumours: an overview. Br J Nurs 25, S12–S15, 2016. doi:10.12968/bjon.2016.25.4.S12.
- Niederle MB, Hackl M, Kaserer K, and Niederle B: Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters. Endocr Relat Cancer 17, 909–918, 2010. doi:10.1677/ERC-10-0152.
- Bikle DD: Vitamin D insufficiency/deficiency in gastrointestinal disorders. J Bone Miner Res 22(Suppl 2), V50–V54, 2007. doi:10.1359/jbmr.07s208.
- Massironi S, Zilli A, Bernasconi S, Fanetti I, Cavalcoli F, et al.: Impact of vitamin D on the clinical outcome of gastro-entero-pancreatic neuroendocrine neoplasms: report on a series from a single institute. Neuroendocrinology 105, 403–411, 2017. doi:10.1159/000456619.
- Qureshi SA, Burch N, Druce M, Hattersley JG, Khan S, et al.: Screening for malnutrition in patients with gastro-entero-pancreatic neuroendocrine tumours: a cross-sectional study. BMJ Open 6, e010765, 2016. doi:10.1136/bmjopen-2015-010765.
- Fiebrich HB, Van Den Berg G, Kema IP, Links TP, Kleibeuker JH, et al.: Deficiencies in fat-soluble vitamins in long-term users of somatostatin analogue. Aliment Pharmacol Ther 32, 1398–1404, 2010. doi:10.1111/j.1365-2036.2010.04479.x.
- Lind A, Wangberg B, and Ellegard L: Vitamin D and vitamin B12 deficiencies are common in patients with midgut carcinoid (SI-NET). Eur J Clin Nutr 70, 990–994, 2016. doi:10.1038/ejcn.2016.40.
- Motylewska E, Gawronska J, Niedziela A, Melen-Mucha G, Lawnicka H, et al.: Somatostatin analogs and tumor localization do not influence vitamin D concentration in patients with neuroendocrine tumors. Nutr Cancer 68, 428–434, 2016. doi:10.1080/01635581.2016.1152387.
- Pearce SH and Cheetham TD: Diagnosis and management of vitamin D deficiency. BMJ 340, b5664, 2010. doi:10.1136/bmj.b5664.
- Mallard SR, Howe AS, and Houghton LA: Vitamin D status and weight loss: a systematic review and meta-analysis of randomized and nonrandomized controlled weight-loss trials. Am J Clin Nutr 104, 1151–1159, 2016. doi:10.3945/ajcn.116.136879.
- Barnard K, and Colon-Emeric C: Extraskeletal effects of vitamin D in older adults: cardiovascular disease, mortality, mood, and cognition. Am J Geriatr Pharmacother 8, 4–33, 2010. doi:10.1016/j.amjopharm.2010.02.004.
- Chowdhury R, Kunutsor S, Vitezova A, Oliver-Williams C, Chowdhury S, et al.: Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 348, g1903, 2014. doi:10.1136/bmj.g1903.
- Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Krstic G, et al.: Vitamin D supplementation for prevention of cancer in adults. Cochrane Database Syst Rev CD007469, 2014.
- Kovalenko PL, Zhang Z, Yu JG, Li Y, Clinton SK, et al.: Dietary vitamin D and vitamin D receptor level modulate epithelial cell proliferation and apoptosis in the prostate. Cancer Prev Res (Phila) 4, 1617–1625, 2011. doi:10.1158/1940-6207.CAPR-11-0035.
- Ooi LL, Zhou H, Kalak R, Zheng Y, Conigrave AD, et al.: Vitamin D deficiency promotes human breast cancer growth in a murine model of bone metastasis. Cancer Res 70, 1835–1844, 2010. doi:10.1158/0008-5472.CAN-09-3194.
- Ray R, Banks M, Abuzahra H, Eddy VJ, Persons KS, et al.: Effect of dietary vitamin D and calcium on the growth of androgen-insensitive human prostate tumor in a murine model. Anticancer Res 32, 727–731, 2012.
- Hummel D, Aggarwal A, Borka K, Bajna E, Kallay E, et al.: The vitamin D system is deregulated in pancreatic diseases. J Steroid Biochem Mol Biol 144 Pt B, 402–409, 2014. doi:10.1016/j.jsbmb.2014.07.011.
- Mark KA, Dumas KJ, Bhaumik D, Schilling B, Davis S, et al.: Vitamin D promotes protein homeostasis and longevity via the stress response pathway Genes skn-1, ire-1, and xbp-1. Cell Rep 17, 1227–1237, 2016. doi:10.1016/j.celrep.2016.09.086.
- Jeffreys M, Redaniel MT, and Martin RM: The effect of pre-diagnostic vitamin D supplementation on cancer survival in women: a cohort study within the UK Clinical Practice Research Datalink. BMC Cancer 15, 670, 2015. doi:10.1186/s12885-015-1684-0.
- Rindi G, Kloppel G, Alhman H, Caplin M, Couvelard A, et al.: TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 449, 395–401, 2006. doi:10.1007/s00428-006-0250-1.